Market›Health Care›Biotechnology›Biotechnology
MUSTANG BIO INC

MBIO

$0.75Apr 26, 2021 – Apr 24, 2026
Health CareBiotechnology$6M
MVM
+$0.0M
TD Variance
0.065

Every news event mapped to its market reaction — 102 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2024-06-17+552.8%newsSeeking AlphaMustang Bio stock rockets 580% on blood cancer drug study
2024-06-17+552.8%newsSeeking AlphaMustang Bio stock rockets 580% on blood cancer drug study (NASDAQ:MBIO) - Seeking Alpha
2025-07-07+124.3%legalSeeking AlphaMustang Bio rises after FDA orphan drug status for MB-101
2025-07-07+124.3%legalGlobeNewswireMustang Bio Granted Orphan Drug Designation by U.S. FDA for - GlobeNewswire
2025-07-07+124.3%legalInvestorideas.comBiotech Stock Mustang Bio, Inc. (Nasdaq: MBIO) Soars on Orphan Drug Designation by U.S. FDA - Investorideas.com
2025-07-07+124.3%newstimothysykes.comMustang Bio’s Drastic Turn: Opportunity or Red Flag? - timothysykes.com
2024-06-20-34.0%newsSeeking AlphaMustang Bio announces $2.5M registered direct offering
2024-04-15-30.5%newsSeeking AlphaMustang Bio stock tumbles 27% amid news of mass layoffs
2024-05-21-28.3%legalSEC EDGARMBIO 8-K: 3.01 and 8.01 (SEC Filing)
2025-01-17-28.3%legalSEC EDGARMBIO 8-K: 3.03, 5.03, 8.01 (SEC Filing)
2025-02-27-28.3%newsSeeking AlphaMustang Bio stock plunges 29% on lease termination news
2025-02-27-28.3%legalSEC EDGARMBIO 8-K: 2.01, 8.01 (SEC Filing)
2024-06-18-25.2%newsSeeking AlphaMustang Bio stock soars 45% after closing 477% higher in prior session
2024-06-18-25.2%newsCGTLive®Mustang Bio’s CAR-T MB-106 Achieves Responses in 9 of 10 Patients With Waldenstrom Macroglobulinemia - CGTLive®
2024-04-29-20.3%legalSEC EDGARMBIO 8-K: 2.02 (SEC Filing)
2024-04-29-20.3%newsStock TitanMustang Bio Announces Pricing of $4 Million Public Offering - Stock Titan
2024-05-02+20.1%legalSEC EDGARMBIO 8-K: 1.01, 8.01 (SEC Filing)
2025-01-15-20.0%newsSeeking AlphaMustang Bio files to sell common stock, warrants
2023-04-03-18.3%newsSeeking AlphaMustang Bio announces 15-for-1 reverse stock split
2023-04-03-18.3%legalSEC EDGARMBIO 8-K: 3.03, 5.03, 8.01 (SEC Filing)
2024-03-11-16.2%earningsSeeking AlphaMustang Bio GAAP EPS of -$6.00 beats by $0.67
2024-03-11-16.2%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2024-05-31-16.2%newsSeeking AlphaMustang Bio files for $40M mixed shelf offering
2023-05-22+15.9%legalSEC EDGARMBIO 8-K: 1.01, 1.02, 2.05, 8.01 (SEC Filing)
2022-06-24-15.6%legalSEC EDGARMBIO 8-K: 5.02, 5.07 (SEC Filing)
2023-08-14-15.5%earningsSeeking AlphaMustang Bio GAAP EPS of -$2.00 misses by $0.19
2023-08-14-15.5%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2022-03-08+14.9%legalSEC EDGARMBIO 8-K: 1.01 and (SEC Filing)
2024-06-06-14.7%legalSEC EDGARMBIO 8-K: 1.01, 1.02 (SEC Filing)
2023-08-16-12.7%newsSeeking AlphaMustang Bio down 8% following data on CAR-T lymphoma asset
2023-08-16-12.7%legalSEC EDGARMBIO 8-K: 8.01 and (SEC Filing)
2024-07-03-12.7%legalSEC EDGARMBIO 8-K: 1.01, 1.02, 2.01, 5.07 (SEC Filing)
2024-03-28+11.9%newsSeeking AlphaMustang Bio stock climbs 9% amid drug development update
2022-03-23+10.5%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2022-03-17+10.1%legalSEC EDGARMBIO 8-K: 5.02 (SEC Filing)
2024-06-24-10.0%legalSEC EDGARMBIO 8-K: 1.01, 3.02, 8.01 (SEC Filing)
2023-12-11-9.3%legalSEC EDGARMBIO 8-K: 8.01 and (SEC Filing)
2023-05-18-9.0%newsSeeking AlphaMustang to sell Worcester site for up to $11M, abandons some CAR T cell programs
2021-11-12-7.6%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2023-10-30+7.5%legalSEC EDGARMBIO 8-K: 1.01, 3.02, 8.01 (SEC Filing)
2025-07-08-7.4%newsZacks Investment ResearchShould I buy Mustang Bio (MBIO) - Zacks Investment Research
2025-07-08-7.4%legalYahoo FinanceMBIO Soars on Orphan Drug Nod for Investigational Brain Cancer Therapy - Yahoo Finance
2023-11-02+7.3%legalSEC EDGARMBIO 8-K: 8.01 and (SEC Filing)
2024-11-22-6.9%newsSeeking AlphaMustang Bio files to sell 34.77M shares of common stock for holders
2022-05-12+6.7%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2025-12-23-6.2%legalSEC EDGARMBIO 8-K: 5.07, 8.01 (SEC Filing)
2026-04-20-6.2%newsMSNMSN Money - MSN
2026-04-20-6.2%newsXã Châu ThànhMustang Bio (MBIO) Stock: Momentum Outlook (-1.95%) 2026-04-20 - Real Trader Network - Xã Châu Thành
2026-04-20-6.2%newsCổng thông tin điện tử tỉnh Lào CaiMustang Bio (MBIO) Stock: Momentum Outlook (-1.95%) 2026-04-20 - Reversal Setup - Cổng thông tin điện tử tỉnh Lào Cai
2026-03-24-6.1%legalAD HOC NEWSMustang Bio Inc stock faces prolonged decline amid biotech sector volatility and pipeline uncertaint - AD HOC NEWS
2024-07-19-5.9%newsSeeking AlphaMustang Bio files to sell 6.5M shares by holders
2024-11-15-5.9%legalSEC EDGARMBIO 8-K: 3.01 and 5.02 (SEC Filing)
2023-01-27-5.6%newsSeeking AlphaMustang Bio (MBIO) Investor Presentation - Slideshow
2022-12-13-5.6%legalSEC EDGARMBIO 8-K: 1.01 and (SEC Filing)
2022-09-23-5.6%newsSeeking AlphaMustang Bio: This Horse May Gallop Still
2021-08-16+5.5%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2023-04-20+5.4%legalSEC EDGARMBIO 8-K: 8.01 and (SEC Filing)
2023-11-14+5.2%earningsSeeking AlphaMustang Bio GAAP EPS of -$1.23 beats by $0.04
2023-11-14+5.2%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2023-07-31+5.1%legalSEC EDGARMBIO 8-K: 1.01, 2.01 (SEC Filing)
2024-11-07+5.0%legalSeeking AlphaMustang Bio granted orphan drug designation by FDA for its malignant glioma treatment
2023-05-12-5.0%earningsSeeking AlphaMustang Bio GAAP EPS of -$2.06 beats by $0.95
2023-05-12-5.0%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2024-03-15+4.9%newsSeeking AlphaMustang Bio files to sell common stocks, warrants, no amount given
2026-04-06-4.9%analystUBND thành phố Hải PhòngIs Mustang Bio (MBIO) Stock Declining | Price at $0.76, Down 1.68% - Senior Analyst Forecasts - UBND thành phố Hải Phòng
2026-04-10-4.8%newsCổng thông tin điện tử Tỉnh Sơn LaIs Mustang Bio (MBIO) Stock slowing down | Price at $0.74, Down 0.40% - RSI Overbought Stocks - Cổng thông tin điện tử Tỉnh Sơn La
2021-05-14+4.6%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2024-01-25+4.0%legalSEC EDGARMBIO 8-K: 5.02 and (SEC Filing)
2024-10-25+3.9%legalSEC EDGARMBIO 8-K: 1.01, 3.02, 5.02, 8.01 (SEC Filing)
2023-03-29+3.8%earningsSeeking AlphaMustang Bio GAAP EPS of -$0.75 beats by $0.01
2023-03-29+3.8%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2025-03-05-3.6%newsSeeking AlphaMustang Bio regains compliance with Nasdaq Capital Market requirement
2025-03-05-3.6%legalSEC EDGARMBIO 8-K: 8.01 and (SEC Filing)
2025-02-13-3.5%legalSEC EDGARMBIO 8-K: 1.01 and 1.02 (SEC Filing)
2026-04-17-3.0%newsStock TitanNasdaq warns Mustang Bio (MBIO) on sub-$1 share price and listing risk - Stock Titan
2026-04-08-2.9%newsXã Vĩnh CôngWhat is the future of Mustang Bio (MBIO) Stock | Price at $0.74, Up 0.27% - Buy Zone Stocks - Xã Vĩnh Công
2023-10-26-2.8%legalSeeking AlphaMustang Bio stock jumps 10% on FDA acceptance of new drug application
2023-10-26-2.8%legalSEC EDGARMBIO 8-K: 8.01 and (SEC Filing)
2026-02-13-2.4%newsIntellectia AIMBIO Should I Buy - Intellectia AI
2022-08-17-2.4%newsSeeking AlphaMustang Bio (MBIO) Corporate Presentation - Slideshow
2024-01-18-2.1%newsCNNsymbol__ Stock Quote Price and Forecast - CNN
2023-06-30-2.1%legalSEC EDGARMBIO 8-K: 1.01 and (SEC Filing)
2024-11-06-2.1%legalSEC EDGARMBIO 8-K: 5.08 and 8.01 (SEC Filing)
2023-10-04+1.9%legalSEC EDGARMBIO 8-K: 8.01 (SEC Filing)
2025-02-11-1.8%newsSeeking AlphaMustang Bio regains compliance with Nasdaq minimum bid price requirement
2025-02-11-1.8%legalSEC EDGARMBIO 8-K: 1.01, 8.01 (SEC Filing)
2022-11-25+1.6%legalSEC EDGARMBIO 8-K: 8.01 (SEC Filing)
2024-01-04-1.3%legalSEC EDGARMBIO 8-K: 8.01 (SEC Filing)
2022-11-14+1.3%earningsSeeking AlphaMustang Bio GAAP EPS of -$0.18 beats by $0.02
2022-11-14+1.3%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2024-03-29+1.1%legalSEC EDGARMBIO 8-K: 8.01 (SEC Filing)
2022-08-11+0.9%earningsSeeking AlphaMustang Bio GAAP EPS of -$0.19 beats by $0.02
2022-08-11+0.9%legalSEC EDGARMBIO 8-K: 2.02 and (SEC Filing)
2022-08-14-0.4%analystZacks Investment ResearchWhat is the current Price Target and Forecast for Mustang Bio (MBIO) - Zacks Investment Research
2023-06-23-0.3%legalSEC EDGARMBIO 8-K: 5.02, 5.07 (SEC Filing)
2023-07-20+0.3%legalSEC EDGARMBIO 8-K: 1.01 and (SEC Filing)
2023-12-12+0.3%newsSeeking AlphaMustang Bio files to sell 2.74M shares of common stock for holders
2023-12-12+0.3%legalSEC EDGARMBIO 8-K: 5.02 (SEC Filing)
2022-04-22+0.3%legalSEC EDGARMBIO 8-K: 5.02 and (SEC Filing)
2025-07-09-0.1%legalSEC EDGARMBIO 8-K: 8.01 and (SEC Filing)
2024-02-14-0.1%legalSEC EDGARMBIO 8-K: 8.01 (SEC Filing)
2024-05-11-0.0%earningsMarketBeatMustang Bio (MBIO) Stock Forecast and Price Target 2026 - MarketBeat
tickerdossier.comtickerdossier.substack.com